Equities research analysts at Leerink Partners assumed coverage on shares of Elanco Animal Health (NYSE:ELAN – Get Free ...
Amylin analogs present a strong alternative or complement to GLP-1 receptor agonists, potentially eliciting higher-quality ...
Investment analysts at Leerink Partners began coverage on shares of Climb Bio (NASDAQ:CLYM – Get Free Report) in a report released on Monday, MarketBeat reports. The brokerage set an “outperform” ...
BOSTON, Oct. 22, 2024 /PRNewswire/ -- Leerink Partners' affiliate, MEDACorp, announced today the launch of a new division, the Center for Pharmacoeconomics (CPE), which will be dedicated to ...
Fintel reports that on December 2, 2024, Leerink Partners initiated coverage of Zoetis (NYSE:ZTS) with a Outperform ...
Fintel on MSN2d
Leerink Partners Initiates Coverage of Elanco Animal Health (ELAN) with Market Perform RecommendationFintel reports that on December 2, 2024, Leerink Partners initiated coverage of Elanco Animal Health (NYSE:ELAN) with a ...
AbbVie (ABBV) shares jump after Leerink Partners upgraded the stock to Outperform, saying the recent sell-off creates an ...
Industry Veterans Grant Curry and Jason Truman Join Leerink Partners. BOSTON, Nov. 14, 2024 /PRNewswire/ -- Leerink Partners, a leading investment bank specializing in healthcare, announced today ...
Fintel reports that on November 22, 2024, Leerink Partners upgraded their outlook for AbbVie (NYSE:ABBV) from Market Perform to Outperform. As of November 20, 2024, the average one-year price ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback